Applied DNA Sciences Anti-theft Technology Adopted by European Car Makers
STONY BROOK, NY, October 30, 2014. Applied DNA Sciences, Inc. (OTCQB: APDND), (Twitter: @APDN), a biotechnology firm that provides DNA-based authentication and security solutions and services, announced today that the company's technology is protecting European automotive manufacturers against the theft of automotive parts.
Two well-known automakers have chosen to use Applied DNA Sciences' anti-theft DNA marking technology to protect their vehicles imported into at least one EU country. New orders have been received within the week.
For each vehicle, a unique, botanical DNA-based mark is designed and applied to a vehicle in multiple locations. The SigNature® DNA mark provides absolute identification for the vehicle, while also recording the name of the owner of that vehicle in a secure database. The marks are covert and difficult to remove. If found, vehicles and their component parts are traceable back to its owner and location, from anywhere on the globe.
Said Dr. James A. Hayward, CEO and President of Applied DNA Sciences: "We continue to grow our portfolio of anti-theft products and to demonstrate the creativity and versatility of this technology. As a package, we believe the system is unique in offering crime deterrence as well as recovery."
About Applied DNA Sciences
APDND is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDND may be forward-looking in nature. Forward-looking statements describe APDND's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDND. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDND's SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q. APDND undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
media contact Mitchell Miller, 631-240-8818
investor contact Debbie Bailey, 631-240-8817
web www.adnas.com
twitter @APDN, @APDNInvestor.
Applied DNA Sciences | 50 Health Sciences Drive | Stony Brook | NY | 11790
AI
